These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 10712946)

  • 1. Lineage commitment in lymphopoiesis.
    Busslinger M; Nutt SL; Rolink AG
    Curr Opin Immunol; 2000 Apr; 12(2):151-8. PubMed ID: 10712946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coordinate regulation of B cell differentiation by the transcription factors EBF and E2A.
    O'Riordan M; Grosschedl R
    Immunity; 1999 Jul; 11(1):21-31. PubMed ID: 10435576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymphoid precursors.
    Akashi K; Reya T; Dalma-Weiszhausz D; Weissman IL
    Curr Opin Immunol; 2000 Apr; 12(2):144-50. PubMed ID: 10712944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphopoiesis. Transcription factors controlling B-cell development.
    Desiderio S
    Curr Biol; 1995 Jun; 5(6):605-8. PubMed ID: 7552167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Commitment to the B-lymphoid lineage depends on the transcription factor Pax5.
    Nutt SL; Heavey B; Rolink AG; Busslinger M
    Nature; 1999 Oct; 401(6753):556-62. PubMed ID: 10524622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of lineage commitment during lymphocyte development.
    Staal FJ; Clevers HC
    Int Rev Immunol; 2001 Feb; 20(1):45-64. PubMed ID: 11342297
    [No Abstract]   [Full Text] [Related]  

  • 7. Induction of early B cell factor (EBF) and multiple B lineage genes by the basic helix-loop-helix transcription factor E12.
    Kee BL; Murre C
    J Exp Med; 1998 Aug; 188(4):699-713. PubMed ID: 9705952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The basic helix-loop-helix transcription factor E2-2 is involved in T lymphocyte development.
    Bergqvist I; Eriksson M; Saarikettu J; Eriksson B; Corneliussen B; Grundström T; Holmberg D
    Eur J Immunol; 2000 Oct; 30(10):2857-63. PubMed ID: 11069067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term in vivo reconstitution of T-cell development by Pax5-deficient B-cell progenitors.
    Rolink AG; Nutt SL; Melchers F; Busslinger M
    Nature; 1999 Oct; 401(6753):603-6. PubMed ID: 10524629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcription factor regulation of B lineage commitment.
    Kee BL; Murre C
    Curr Opin Immunol; 2001 Apr; 13(2):180-5. PubMed ID: 11228411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of Notch1 function by in vitro T cell differentiation of Pax5 mutant lymphoid progenitors.
    Höflinger S; Kesavan K; Fuxa M; Hutter C; Heavey B; Radtke F; Busslinger M
    J Immunol; 2004 Sep; 173(6):3935-44. PubMed ID: 15356142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pax5 promotes B lymphopoiesis and blocks T cell development by repressing Notch1.
    Souabni A; Cobaleda C; Schebesta M; Busslinger M
    Immunity; 2002 Dec; 17(6):781-93. PubMed ID: 12479824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of EBF function by active Notch signaling reveals a novel regulatory pathway in early B-cell development.
    Smith EM; Akerblad P; Kadesch T; Axelson H; Sigvardsson M
    Blood; 2005 Sep; 106(6):1995-2001. PubMed ID: 15920012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptional control of B-cell development.
    Schebesta M; Heavey B; Busslinger M
    Curr Opin Immunol; 2002 Apr; 14(2):216-23. PubMed ID: 11869895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term cultured E2A-deficient hematopoietic progenitor cells are pluripotent.
    Ikawa T; Kawamoto H; Wright LY; Murre C
    Immunity; 2004 Mar; 20(3):349-60. PubMed ID: 15030778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcription factor EBF restricts alternative lineage options and promotes B cell fate commitment independently of Pax5.
    Pongubala JM; Northrup DL; Lancki DW; Medina KL; Treiber T; Bertolino E; Thomas M; Grosschedl R; Allman D; Singh H
    Nat Immunol; 2008 Feb; 9(2):203-15. PubMed ID: 18176567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pax5 determines the identity of B cells from the beginning to the end of B-lymphopoiesis.
    Nutt SL; Eberhard D; Horcher M; Rolink AG; Busslinger M
    Int Rev Immunol; 2001 Feb; 20(1):65-82. PubMed ID: 11342298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oscillation between B-lymphoid and myeloid lineages in Myc-induced hematopoietic tumors following spontaneous silencing/reactivation of the EBF/Pax5 pathway.
    Yu D; Allman D; Goldschmidt MH; Atchison ML; Monroe JG; Thomas-Tikhonenko A
    Blood; 2003 Mar; 101(5):1950-5. PubMed ID: 12406913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Restricted STAT5 activation dictates appropriate thymic B versus T cell lineage commitment.
    Goetz CA; Harmon IR; O'Neil JJ; Burchill MA; Johanns TM; Farrar MA
    J Immunol; 2005 Jun; 174(12):7753-63. PubMed ID: 15944278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. B-cell commitment: Pax5 is the deciding factor.
    Enver T
    Curr Biol; 1999 Dec 16-30; 9(24):R933-5. PubMed ID: 10607584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.